Author:
Kato Masaki,Chang Chia-Ming
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)
Reference29 articles.
1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–105. Epub 2003/06/19.
2. Kawakami N. Epidemiology of depressive disorders in Japan and the world. Nihon Rinsho. 2007;65(9):1578–84. Epub 2007/09/20.
3. Cho MJ, Chang SM, Hahm BJ, Chung IW, Bae A, Lee YM, et al. Lifetime risk and age of onset distributions of psychiatric disorders: analysis of national sample survey in South Korea. Soc Psychiatry Psychiatr Epidemiol. 2012;47(5):671–81. Epub 2011/04/30.
4. Nelson CJ. The use of antipsychotic drugs in the treatment of depression, in Treating Resistant Depression. In: Zohar J, Belmaker R, editors. New York: PMA Publishing; 1987. p. 131–46.
5. Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry. 2009;166(9):980–91. Epub 2009/08/19.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献